In an attempt to incentivize the development of new medical devices to treat or prevent opioid use disorder, the US Food and Drug Administration (FDA) on Wednesday announced an "innovation challenge" for device makers that will run from 1 June to 30 September 2018.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,